Security key
29842P105
EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (EPRX)
CUSIP: 29842P105
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 1,826,270
- Total 13F value
- $5,634,759
- Share change
- +15,689
- SEC-reported price per share
- $3.17
- Number of holders
- 9
- Value change
- +$50,501
- Number of buys
- 3
- Number of sells
- 5
- Shares outstanding
- 52,146,078
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
9
Top holders
9
EPRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
EUPRAXIA PHARMACEUTICALS INC. SEC filings
EUPRAXIA PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29842P105
Recent filing periods:
Ownership snapshot
Top reported holders of EPRX - EUPRAXIA PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SCOTIA CAPITAL INC.
Disclosed value leader
SCOTIA CAPITAL INC.
Comparable rows
8/8
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 2.7%
Showing 1-6 of 8 holder rows.
Quick read
SCOTIA CAPITAL INC. leads the comparable SEC ownership view at 2.7%.
8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SCOTIA CAPITAL INC.'s linked filing trail.
Comparable ownership
Top 5
SCOTIA CAPITAL INC.
2.7%
ROYAL BANK OF CANADA
0.52%
BANK OF MONTREAL /CAN/
0.09%
GOLDMAN SACHS GROUP INC
0.07%
UBS Group AG
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SCOTIA CAPITAL INC. |
13F
Company
|
2.7%
|
$3,489,819
1,396,281 shares
|
— | 30 Sep 2024 |
| ROYAL BANK OF CANADA |
13F
Company
|
0.52%
|
$714,000
271,287 shares
|
— | 30 Sep 2024 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
0.09%
|
$125,982
49,250 shares
|
— | 30 Sep 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.07%
|
$90,735
34,500 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
0.06%
|
$86,790
33,000 shares
|
— | 30 Sep 2024 |
| 180 WEALTH ADVISORS, LLC |
13F
Company
|
0.02%
|
$34,190
13,000 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
1,826,270
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
53
Q4 2024 holders
9
Holder diff
-44
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend